Back to Search Start Over

Alembic Pharmaceuticals gets USFDA's final approval for Diclofenac Sodium Topical Solution.

Source :
Ace Analyser: Company News; 12/1/2022, pN.PAG-N.PAG, 1p
Publication Year :
2022

Abstract

Diclofenac Sodium Topical Solution is indicated for the treatment of the pain of osteoarthritis of the knee(s) [ABSTRACT FROM AUTHOR]

Subjects

Subjects :
DRUG approval
DICLOFENAC
KNEE osteoarthritis
PAIN management
DRUGS

Details

Language :
English
Database :
Complementary Index
Journal :
Ace Analyser: Company News
Publication Type :
Report
Accession number :
160533621

Tools

Authors Abstract Subjects Details